| 000 | 01115 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516180739.0 | ||
| 264 | 0 | _c20140703 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1548-5609 | ||
| 024 | 7 |
_a10.1053/j.ackd.2013.06.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZuckerman, Jonathan E | |
| 245 | 0 | 0 |
_aTargeting therapeutics to the glomerulus with nanoparticles. _h[electronic resource] |
| 260 |
_bAdvances in chronic kidney disease _cNov 2013 |
||
| 300 |
_a500-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aGlomerulonephritis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Glomerulus _xmetabolism |
| 650 | 0 | 4 |
_aNanoparticles _xtherapeutic use |
| 700 | 1 | _aDavis, Mark E | |
| 773 | 0 |
_tAdvances in chronic kidney disease _gvol. 20 _gno. 6 _gp. 500-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ackd.2013.06.003 _zAvailable from publisher's website |
| 999 |
_c23245205 _d23245205 |
||